30 closest matches · ranked by relevance
Infertility Unexplained · Infertility, Male · DNA Damage
Primary: DNA Fragmentation as a Predictor of Live Birth Rate — 32 Participants — p=0.04
Male Infertility · Unexplained Infertility · Abortion, Habitual
Primary: Pregnancy — 67; 80 participants
Sperm DNA Fragmentation · Embryo Quality · Fertility Disorders
Primary: Day 3 High Quality Embryo Percentage — 68; 66 percentage of high quality embryos
Infertility, Male · Depression
Primary: Number of Participants With Abnormal Sperm DNA Fragmentation at 6 Weeks — 0; 2 Participants
ART
Primary: Percentage of Good Quality Blastocyst Formation — 51.4; 51.7 percentage of embryos
Infertility, Male
Primary: Sperm Progressive Motility — 19.62; 25.11 percentage
Pregnancy · Live Birth · Spontaneous Abortion
Primary: Live Birth — 404; 416; 97; 91 Participants
Reproductive Sterility
Primary: Number of Control and Treated Participants With Successful Live Births Following Conventional IVF or ICSI Cycles — 18; 13; 8; 9 participants
Infertility
Primary: Number of Metaphase II (MII) — 4; 2 Oocytes — p=0.302
Prostate Cancer
Primary: Fold-change Post Flutamide Exposure — 5.860 Fold-change
Male Infertility
Primary: Live Birth Rate — 15.3; 22.1 percentage of live births
Male Infertility, Azoospermia
Primary: Total Motile Sperm — 8; 1 Participants
Healthy
Primary: Semen Volume — 2.55 mL
Erectile Dysfunction
Primary: Percentage of Subjects With a Greater Than or Equal to 50% Decrease in Sperm Concentration From Baseline to Week 26 — 1.5; 14.5 percentage of participants
Infertility, Male
Primary: Fertility Preservation (FP) Uptake — 10; 9 Participants — p==.64
Circulating Cell Free Fetal DNA · Intrauterine Fetal Demise · Miscarriage
Primary: The Presence or Absence of Cell Free Fetal DNA in Maternal Blood in the Setting of a Failed Pregnancy. — 50 percentage of participants
Colorectal Cancer
Primary: Gamma H2AX Histone Levels in Colonic Biopsy During Standard White Light Colonoscopy and Colonoscopy for Which Methylene Blue MMX Was Taken Prior to Initiating the…
Infertility
Primary: Clinical Pregnancy — 71 participants
Analytical Reproducibility of a Medical Device
Primary: Percentage of Correct Calls to Assess Reproducibility of the Spartan FRX CYP2C19 System. — 98.3; 100; 97.5; 99.2 Percentage of Correct Calls
Pregnancy
Primary: The Percentage of Patients With a Live Birth — 45; 65 Participants
Genotyping Techniques
Primary: Percent Agreement — 100; 100; 100; 100 Percent Agreement
Male Infertility · Obesity · Weight Loss
Primary: Sperm Concentration — 53.6; 58.5; 20.1; 15 million sperms/mL
Male Infertility · Klinefelter's Syndrome · Y-chromosome Microdeletions
Primary: Millions of Sperm Per Ejaculate — 2.5; 3.8 Millions of sperm per ejaculate
Human Immunodeficiency Virus · Virus Shedding
Primary: Semen Clearance (CL) of Tenofovir — 33.88; 51.21; 5.65 L/hr
Anovulation
Primary: Endometrial Thickness — 6.6; 9.3 millimeter
Reproductive Techniques, Assisted
Primary: Number of Oocytes Retrieved — 24.77; 22.57 oocytes retrieved — p=0.2629
Fertility, Male · Sub-Fertility, Male
Primary: Number of Untrained Lay Users That Obtained Accurate and Inaccurate Subfertility Results From the TRAK Device When Compared to Results Obtained From the Gold Standard…
Prostate Cancer
Primary: Proportion of Subjects With a Demethylation Response at Each Dose Level — .22; .30 proportion of participants
Oligospermia
Primary: Changes From Baseline in the Seminal Fluid Characteristics Throughout the Study — 3.47; 3.20 ml
Fetal Structural Anomalies
Primary: Number of Participants Who Had Reportable Variants — 114; 22 Participants